Edition:
United Kingdom

People: Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

18.29CNY
17 Oct 2018
Change (% chg)

¥-0.28 (-1.51%)
Prev Close
¥18.57
Open
¥18.80
Day's High
¥18.92
Day's Low
¥17.62
Volume
7,342,553
Avg. Vol
8,822,188
52-wk High
¥27.29
52-wk Low
¥17.62

Shen, Bo 

Mr. Shen Bo has been serving as Chief Financial Officer, Vice President and Executive Director in Shanghai Pharmaceuticals Holding Co., Ltd. since October 2016. He also serves as Non-Executive Director in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., as well as Chairman of the Board and Director in other four companies. He was Deputy Manager-Finance in Shanghai Jinling Co., Ltd, Chief Financial Officer in Shanghai Industrial Pharmaceutical Investment Co Ltd. and another company, as well as General Manager-Finance in Shanghai Pharmaceutical (Group) Co., Ltd. He holds a Master's degree in Accounting from The Chinese University of Hong Kong and a Bachelor's degree in Accounting from a university which is now called Tongji University, China. He is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, CNY --
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 2,175,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jun Zhou

--

Min Zuo

2,915,700

Bo Shen

2,175,600

Yongzhong Li

528,400

Dawei Liu

354,000

Haoliang Gu

281,900
As Of  31 Dec 2016